The impact of sleeve gastrectomy on recurrent obese hyperlipidemic pancreatitis

Objective To study the impact of weight loss surgery after 3 months of stable condition through intervention on patients with obese hyperlipidemic acute pancreatitis (HLAP). Methods Ten patients with obese HLAP who underwent laparoscopic sleeve gastrectomy (LSG) at the General Surgery Department of our hospital were followed-up at 1, 3, 6, 12, 24 months after surgery. Their weight, BMI, EWL, and blood parameters (TG, LDL-C, HDL-C, TC, FPG, HbA1c, UA, hs-CRP, ESR, and hemorheology indexes) were compared. The impact on postoperative obese HLAP was assessed. Results The weight, BMI, EWL and blood index (TG, LDL-C, HDL-C, TC, FPG, HbA1c, UA, hs-CRP, ESR, and hemorheology indexes) of the patients gradually decreased. The decrease was significantly different from that before surgery (P<0.05), which became stable at 12 months and with no recurrence at 24 months after surgery. Conclusions LSG reduced body weight and improved metabolic status of the patients. It stopped the occurrence of obese HLAP. LSG can be used as an effective intervention for patients with obese HLAP. Key words: Hyperlipidemic acute pancreatitis (HLAP); Obese; Sleeve gastrectomy (LSG)